Provided by:
This activity is supported by an educational
grant from Baxter Healthcare Corporation:
Hemophilia Treatment Options
Presented by: Jennifer Maahs, RN, PNP, MSN
Indiana Thrombosis and Hemostasis Center, Indianapolis, IN
Program Goal:
The goal of this knowledge based program is to provide an overview of the treatment options available to hemophilia patients, including factor concentrates and dosing information, therapy options and supportive therapies.
Learning Objectives:
Upon completion of this educational activity the participant will be able to:
- Discuss the history and background of hemophilia
- Explain treatment and prevention of bleeding episodes
- Describe current treatment options in hemophilia
- Review supportive therapies
Fee Information:
There is no fee for this educational activity.
Disclosure of Conflicts of Interest:
SolutionSight, Inc. assess any conflicts of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by SolutionSight, Inc. for: fair balance, scientific objectivity of studies utilized in this activity and patient care recommendations. SolutionSight, Inc. is committed to providing its learners with high-quality CE activities and related materials that promote improvements in the quality of healthcare and not a specific proprietary business interest and/or commercial interest. SolutionSight, Inc.'s findings are listed below.
| Name of Faculty / Speaker |
Reported Areas of Conflict |
| Regina Butler, RN |
Consulting Fees - Bayer, Novo, Wyeth |
| Sue Geraghty, RN, MBA |
Consulting Fees - Baxter, Novo, ZLB |
| Jennifer Maahs, RN, PNP, MSN - Speaker |
|
| Name of Planner(s) |
Reported Areas of Conflict |
| Megan Morash, RN, BSN, MEd |
Consulting Fees - Baxter; Ownership Interest, Baxter Stock |
| Diane Nitzki-George, RPh, MBA |
Consulting Fees - Baxter; Ownership Interest, Baxter Stock |
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. SolutionSight do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SolutionSight. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.
Target Audience:
Clinicians involved in the care of individuals with hemphilia, including nurses and pharmacists.
Initial Release Date:
February 27, 2009
|
Speakers:
|
|
|
|
Jennifer Maahs, PNP, MSN, RN
|
| |
Details:
This event has limited enrollment, so you must pre-register to attend.
Target Audience:
Clinicians involved in the care of individuals with hemophilia, including nurses and pharmacists.
Time: 01:00 to 02:00 pm ET
12:00 to 01:00 pm CT
11:00 to 12:00 am MT
10:00 to 11:00 am PT
Location: Internet Broadcast - RxSchool Live E-Classroom
To receive CE credit, participants must complete an online evaluation form for each session attended. After completing the evaluation, you can view, print and track your CE statements of credit online.
There is no fee to participate in this activity.
|
